Dr. Oh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10833 Le Conte Ave
60-054
Los Angeles, CA 90095
Education & Training
- Yale School of MedicineClass of 2015
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- CA State Medical License 2020 - 2026
- IL State Medical License 2018 - 2020
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Characteristics of a CCL21 Gene-Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non-Small Cell Lung Cancer.Michael S Oh, Camelia Dumitras, Ramin Salehi-Rad, Linh M Tran, Kostyantyn Krysan
Molecular Cancer Therapeutics. 2025-02-04 - 9 citationsCXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer.Raymond J Lim, Ramin Salehi-Rad, Linh M Tran, Michael S Oh, Camelia Dumitras
Cell Reports. Medicine. 2024-04-16 - 4 citationsDendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment.Jensen Abascal, Michael S Oh, Elvira L Liclican, Steven M Dubinett, Ramin Salehi-Rad
Cells. 2023-10-04
Press Mentions
- Genetically Engineered Dendritic Cells Enhance the Power of Immunotherapy Against Lung CancerMarch 26th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: